Related by context. All words. (Click for frequent words.) 61 License Agreement 59 sublicensed 55 sublicensing 54 Licensing Agreement 54 sublicensee 53 commercialize AzaSite 53 sub licensable 52 licensing agreements 52 grant sublicenses 52 commercialize 52 Collaboration Agreement 51 nonexclusive royalty 51 Licence Agreement 51 InterfeRx 50 sublicenses 50 Commercialization Agreement 50 ImmunoGen maytansinoid TAP 50 nonexclusive 50 sublicense agreements 50 Master License Agreement 50 License Option Agreement 50 LFRP 49 Kaketsuken 49 Inc. QWIPTECH holds 49 exclusive sublicense 49 subsidiary QWIP Technologies 48 Zor Pharmaceuticals 48 commercialize taliglucerase alfa 48 exclusive licensee 48 commercialize telaprevir 48 Distribution Agreement 48 MorphoSys proprietary 48 Santen Pharmaceutical Co. 48 Mundipharma 47 Nycomed GmbH 47 BioZone 47 CRADA 47 Handok 47 Exclusive License 47 commercialize XL# 47 Nippon Shinyaku 47 nonexclusive license 47 Galderma SA 47 BioOne Corporation 47 VITAGEL 47 Sublicense 47 Syntiron 47 Symphony Allegro 46 Oncolys 46 Osiris retains 46 MedGenesis 46 Galenea 46 Fresenius Biotech 46 anti CD3 monoclonal 46 Patent License Agreement 46 licensor 46 Option Agreement 46 Creative Commons Attribution 46 Termination Agreement 46 Joint Venture Agreement 46 Chemo Sero Therapeutic 45 fipamezole 45 Fortical ® 45 AnGes 45 Licentia 45 perpetual irrevocable 45 upfront payment 45 Exclusive License Agreement 45 Assignment Agreement 45 Juvantia 45 Alfa Wassermann 45 commercialize lorcaserin 45 Nippon Kayaku 45 Taiho Pharmaceutical 45 CIMAB SA 45 Astellas Deutschland GmbH 45 PerClot 45 EXACT maintains 45 licensee 45 Caleco 45 EGRIFTA TM 45 lixivaptan 45 amino acid naturally occurring 45 Zenyaku Kogyo 45 STRIANT ® 45 Cenomed 44 RESTASIS ® 44 irrevocable perpetual 44 Argatroban 44 Myrexis 44 InvaGen 44 Sublicense Agreement 44 Rottapharm Madaus 44 Teijin Pharma Limited 44 AnGes MG Inc. 44 xi Immtech ability 44 pSivida owns 44 Biovail Laboratories International 44 Nascobal 44 Scantek 44 Trademark License Agreement 44 proprietary MSCRAMM ® 44 perpetual irrevocable non 44 commercialize Vanda 44 Vertex retains 44 prostone 44 ZBx 44 Indaflex 44 Medicis Pediatrics Inc. 44 Hitachi GST trademarks 44 Kyowa Hakko Kogyo Co. 44 sublicensees 44 Canadian drugmaker Aeterna 44 valtorcitabine 44 Kedrion 44 Sensipar R 44 Crucell PER.C6 ® 44 developing TB4 44 Handok Pharmaceuticals 44 CIMAB 44 Synerx 44 CJ CheilJedang Corp. 43 Helsinn Healthcare SA 43 Zeatin 43 Orphan Therapeutics 43 Biovail Laboratories 43 exclusive licensor 43 OMJPI 43 Mitsubishi Tanabe Pharma 43 CFFT 43 POTELLIGENT R Technology 43 POTELLIGENT R 43 SOLODYN R 43 Elan Pharma 43 farmin agreement 43 codevelop 43 Kissei Pharmaceuticals 43 TAGI Pharma 43 Kyowa Hakko Kirin 43 PentaLyte 43 Announce Licensing 43 Biosense 43 Uracyst R 43 Asset Purchase Agreement 43 Sigma Tau Pharmaceuticals 43 PDL antibody humanization 43 commercialize SB# 43 PharmaBio 43 drillsite agreement 43 ddRNAi 43 commercialize omecamtiv mecarbil 43 Crucell PER.C6 43 Returns Royalty 43 promote ceftobiprole 43 Allos retains exclusive 43 GenWay Biotech 43 Roche SWX ROG 43 Portola Pharmaceuticals Inc. 43 Syntonix 43 free perpetual irrevocable 43 Rotarix R 43 co licensor KDL 43 LGLS 43 Prometheus Laboratories 43 Daiichi Suntory Pharma 43 Teijin Pharma 43 SpeBio joint venture 43 commercialize XP# 43 EMD Biosciences Inc. 43 Accelr8 licenses 43 Tanabe Seiyaku 43 MOSAID patents 43 adult multipotent stem 43 Biomedica 43 PROCAPS 43 Tego IP 43 Hextend R 43 iBioPharma 43 SRL Biovail 43 Uracyst ® 42 Loramyc ™ 42 NV Organon 42 Cabilly patent 42 commercialize dutogliptin 42 Acquires Exclusive 42 hyperimmune products 42 Kosan motilin agonist 42 Novartis NVS Snapshot Report 42 Obtains License 42 Immuron 42 Theragenex 42 InterfeRx license 42 CIMYM 42 Vegenics 42 Acquisition Agreement 42 Novexel 42 EyeTel 42 CIMZIA r 42 Olerup SSP 42 Bio3 Research 42 Tyzeka Sebivo 42 commercialize pimavanserin 42 NovaCal 42 Gentamicin Surgical Implant 42 Bioral Amphotericin B. 42 SansRosa 42 tradename 42 mark LabWindows 42 commercialize OncoGenex lead 42 Government Qualifying Therapeutic 42 Precision BioSciences 42 Supply Agreement 42 Discovery Project QTDP 42 PentaStaph 42 commercialize CK # 42 Urocidin TM 42 Evolva 42 Regeneca 42 Definitive Agreement 42 HFTA 42 Mundipharma International 42 Inc. Nasdaq REFR 42 Ibis T# 42 Taiho Pharmaceutical Co. 42 Epitomics 42 fully sublicensable license 42 Cutanea Life Sciences 42 Distributorship Agreement 42 BioSciences 42 UltiMAb 42 SVRX 42 Vernalis plc 42 Quark Biotech 42 Taisho Pharmaceuticals 42 VaxImmune 42 ViaCord R 42 Amended Agreement 42 ATL# [002] 42 outlicensing 42 TRANSDUR Sufentanil 42 XERECEPT R 42 Bioral 42 PER.C6 r 42 LentiVector 42 Lescarden 42 nonexclusive licenses 42 Revance 42 Creative Commons Attribution ShareAlike 42 Albugon 42 Captisol 42 BioSante 2A/Furin technology 42 Registered Trademarks 42 MSCRAMM R 42 Kreutzer Limmer patent 42 RAPTIVA R 42 HepaGam B 42 CEFF financings subject 41 phage display technology 41 Alphapharm 41 NeoVisc R 41 apaziquone 41 DermaSphere R Technology 41 Captisol ® 41 PER.C6 41 Cardium Therapeutics TM 41 Zygogen 41 LOI 41 Misonix Announces 41 Debt Settlement Agreements 41 Exelixis logo 41 Vytex Natural Rubber Latex 41 DNA methylation biomarkers 41 Daewoong 41 Calixa 41 ThyroTec LLC 41 ACTCellerate 41 RYZOLT TM 41 Purchase Agreement 41 BioGeneriX 41 DURECT 41 Underlying Option Agreement 41 Luitpold 41 BioGlue R 41 nonexclusive licensing 41 copromotion 41 Pierre Fabre Medicament 41 SARcode 41 Vaccinex 41 refusal ROFR 41 Securities Purchase Agreement 41 Cetrotide R 41 X Ceptor 41 dacetuzumab collaboration 41 Debiopharm 41 EndoBiologics 41 regadenoson 41 BugOil R 41 evYsio Medical Devices 41 Oracea ® 41 Rexahn licensees 41 LUCASSIN 41 Holodniy 41 S2 Therapeutics 41 ImmunoGen TAP technology 41 Atugen 41 Abbotly 41 COMPLEGENT TM Technologies 41 CLTI 41 Amplimmune 41 AkaRx 41 Veregen R 41 RECOTHROM ® 41 ularitide 41 Obtains Exclusive License 41 Orapred ODT 41 Oncaspar 41 biosimulation 41 Development Agreement CRADA 41 Septin 9 41 AdnaGen 41 All SPARC trademarks 41 commercialize JX 41 Lexiscan R 41 Nasdaq ALNY 41 DiaPep# 41 Neurimmune 41 Enters Into Licensing Agreement 41 CuraGen patents 41 Fumapharm 41 Naglazyme R 41 commercialize becocalcidiol patented 41 tafluprost 41 intellectualproperty 41 TIMERx 41 XERECEPT 41 RTP #i 41 OpenArray ® 41 Golden Tapajos 41 worldwide perpetual irrevocable 41 DFB Biotech 41 TM MMP Portfolio 41 Alnylam RNAi 41 Cytokinetics specified 41 Ophthotech 41 Spirogen 41 Seikagaku 41 convertible promissory notes 41 Genaissance 41 Dacetuzumab 41 Klean Prep ® 41 Arrangement Agreement whereby 40 mitiglinide 40 Glufast 40 reproduce modify adapt 40 whereby Marathon PGM 40 sanofi aventis EURONEXT SAN 40 PharmaSwiss SA 40 License Agreements 40 GED aPC 40 proprietary albumin fusion 40 Amunix 40 Maxy G# 40 Dicer Substrate Technology 40 Transfection Reagent 40 commercialize Aganocides 40 custom oligonucleotides 40 Optiquel ™ 40 Anadis 40 Rosetta dependence 40 xii Immtech ability 40 Caliper microfluidics 40 Investigational Device Exemption 40 Exclusive Distribution 40 Agenerase 40 MediBIC 40 Thrombin topical Recombinant 40 Kyowa Kirin 40 NeuroMedix 40 zinc finger nuclease 40 Symphony Icon 40 Shin Poong 40 InterfeRx TM 40 developing biomedical countermeasures 40 obligations hereunder 40 NurOwn tm technology 40 NASDAQ ALNY 40 Medigen 40 REGPARA 40 acne impetigo 40 Asubio Pharma 40 unilaterally terminate 40 Alike license 40 GPR# agonist 40 Teikoku Seiyaku 40 Loan Agreement 40 Potelligent 40 NMP# ® 40 Net Smelter Return 40 Merck Sante sas 40 RenaZorb 40 biotherapeutic drugs 40 Apexigen 40 CLIA certification 40 UGARF 40 GPL v2 40 Bioniche Teoranta 40 Adagen 40 Symphony ViDA 40 Valortim TM 40 epoprostenol sodium 40 Dynepo TM 40 Senju Pharmaceutical Co. 40 Norgine BV 40 Janssen AI 40 overriding royalty 40 Shigamabs ® 40 bilastine 40 Staccato nicotine technology 40 Fovea Pharmaceuticals 40 Gruppo Angelini 40 Genpharm 40 Solasia 40 Prism Pharmaceuticals 40 Phusion Laboratories 40 BioSante licensees 40 NSR Royalty 40 cinacalcet HCl 40 royalty payments 40 Royalty NSR 40 Cellgate Inc. 40 Therapeutic Competitors Report 40 proprietary MSCRAMM R 40 sublease 40 Prednisporin 40 International SRL BLS 40 Itero 40 JUVISTA 40 Celladon Corporation 40 PROLACRIA ™ 40 Celulas Genetica purchased 40 Nabi HB R 40 Ucyclyd Pharma Inc. 40 Tostrex 40 CIP FENOFIBRATE 40 Xyntha 40 Integrated Preclinical 40 HuMax TAC 40 FXRE 40 exclusive revocable 40 Medarex UltiMAb 40 Oxford Nanopore 40 Fortigel 40 net smelter royalty 40 ELEVESS 40 Vantas 40 Material Transfer 40 Chiesi Farmaceutici SpA 40 convertible promissory note 40 Clinuvel Pharmaceuticals 40 Joint Venture JV 40 patent EP# 40 Angelini Labopharm 40 Syntonix Pharmaceuticals 40 No. #.# 40 Janssen Pharmaceutica NV 40 OTC ZEGERID 40 Announce Licensing Agreement 40 LUCENTIS r 40 asimadoline 40 EHT AGN 40 Pandel R 40 Cx# [002] 40 Cellzome 40 NuRx 40 Medarex UltiMAb R 40 Dendritic Nanotechnologies Inc. 40 KaloBios Pharmaceuticals 40 NasdaqGM SPPI 40 Aversion r Technology 40 Ferrer inCode 40 Affymetrix microarray technology 40 DOS# 40 Vivotif 40 SYCREST 40 SMARTICLES 40 outlicensed 40 HepeX B 40 commercialization 40 Affiliation Agreement 40 synthetic retinoid 40 ORADUR ADHD 40 MethyPatch 40 NYSE Amex BTX 40 Bioaccelerate 40 Loramyc TM 40 AERx iDMS 40 KellBenx 39 CCI Pellet Agreements 39 E4U EnWave 39 Dynepo 39 Torii Pharmaceutical 39 Asubio Pharma Co. 39 Pancreate 39 unoprostone isopropyl 39 PDL# 39 UltiMAb ® 39 ZFP technology 39 HuCAL GOLD 39 GlycArt 39 Botaneco 39 Kissei Pharmaceutical 39 INTELLITAB TM 39 RxKinetix 39 PER.C6 ® 39 Oxygent 39 elbion 39 Escrow Agreement 39 AFFITOME 39 Rheoscience 39 owned subsidiary CIMYM 39 CIP TRAMADOL ER 39 Paris IPN Euronext 39 NovaBay NeutroPhase product 39 Medarex logo 39 Neuftec 39 MolecularBreeding 39 Megapharm Ltd. 39 ALN RSV program 39 Vitamin D analogue 39 Akorn Strides 39 TaiGen 39 Distributor Agreement 39 XIAPEX 39 Zenapax 39 Inks Licensing Deal 39 EB# ® 39 Medarex UltiMAb Human 39 Sinuwave 39 outstanding indebtedness 39 Seikagaku Corporation 39 Asentar TM 39 advance Debio 39 P#X# antagonist 39 Biovitrum AB 39 exclusive distributorship 39 HuCAL PLATINUM R 39 Aganocide TM 39 Tacere Therapeutics 39 Microbix Biosystems 39 VirnetX patents 39 ExpoGold 39 Rescula 39 Kreatech 39 Savene ® 39 Nextoy LLC used 39 Pennsaid Plus 39 Zentaris 39 NSR royalty 39 entity NCE 39 Alopexx 39 AskBio 39 MicroDose 39 Stock Purchase Agreement 39 sublicensing rights 39 Euroscreen 39 Kinetin 39 Atrisorb D R 39 resolves patent infringement 39 Rapinyl 39 Takara Bio Inc. 39 Registered Trademark 39 TRANSDUR ™ 39 commercialize Aganocide compounds 39 bioadhesive drug 39 Epson disclaims 39 SUMAVEL 39 topical anti infective 39 Medpharm 39 HepatAssist TM 39 Proprius Pharmaceuticals 39 PolyTherics 39 Preotact ® 39 Purchase Option Agreement 39 BioTie 39 LongRun2 technologies 39 § #.#-#.# 39 Finjan patents 39 Sanswire TAO exclusively 39 Surplus Contract 39 Invicorp R 39 staphylococcal vaccines 39 incorporate CXA 39 Westinghouse Plasma Gasification 39 JHP Pharmaceuticals LLC 39 Senior Secured Convertible Debentures 39 copyright holder Equilibri 39 Estrasorb 39 proprietary phage display 39 Tissue Genesis 39 Teikoku Seiyaku Co. 39 ZALBIN ™ 39 agreementwith 39 DARA logo 39 BioSyent Pharma 39 Aradigm Logo 39 Nascobal ® 39 Virium 39 Chromos 39 commercialize elagolix 39 RetroMetabolic Drug Design 39 indemnification obligations 39 NorDiag 39 ViroChem 39 ZapMedia applied 39 intravenous formulations 39 AIMMS 39 AzaSite Xtra 39 Enhanze 39 Sanctura 39 Phenomix 39 Kwang Dong 39 ASX ANX 39 Eligard ® 39 KeyGene 39 tiered royalties 39 Amending Agreement 39 Licensing Agreements 39 Potelligent Technology 39 Bao Tai 39 calcitonin manufacturing 39 bioREV 39 antiinfective 39 Rotarix ® 39 rThrombin 39 secured convertible debentures 39 GNU Lesser General 39 RAPIACTA ® 39 Licensor 39 BioGeneriX AG 39 NitroMist 39 Japanese Encephalitis Vaccine 39 creative commons 39 Kissei Pharmaceutical Co. 39 Immunotope 39 definitive agreement 39 Optionor 39 AngioGenex 39 biobased succinic acid 39 Azimuth Opportunity Ltd. 39 Alnylam dependence 39 DepoBupivacaine TM 39 Clean Diesel patented 38 Preotact 38 Samjin 38 JT Torii 38 bepotastine 38 vinorelbine emulsion 38 Hyperion Catalysis International 38 adenosine injection 38 Gruenenthal 38 Harbor BioSciences 38 Toxin Alert 38 Return NSR 38 CysDisplay R 38 ProQuin XR 38 farmout agreement 38 Reseller Agreement 38 Biotica 38 Sontra 38 Manapol R 38 Farmout Agreement 38 Recombinant Protein 38 Virdante 38 RiVax ™ 38 successfully commercialize Silenor 38 Creative Commons licenses 38 Magicalia privacy 38 Calixa Therapeutics 38 PolyNovo 38 Commercialize 38 Genpharm Inc. 38 Inc. AMEX CTT 38 OceanBASIS 38 Migami 38 Sirius Genomics 38 Galephar 38 ForSight Newco II 38 NeutroPhase TM 38 ProEthic Pharmaceuticals 38 PreciseTrader.com 38 HuCAL GOLD R 38 Announces License Agreement 38 MSc Qualified Person 38 Femprox 38 Fast Track designations 38 commercialize peramivir 38 FineTech 38 GPSi Asia 38 Botaneco Specialty Ingredients 38 rxRNA 38 Nasdaq IDEV 38 proprietary Lipid Vector 38 evYsio 38 Perlegen Sciences 38 absorbable powder hemostat 38 ZZP Merger ZZUSA 38 Visual Voicemail patents 38 Eligard R 38 Onconome 38 Participation Agreement 38 commercialize Hematide 38 VIRUSMAX 38 RenaZorb TM 38 sublicensing agreements 38 PN# [001] 38 Zovirax ® 38 Licensing Deal 38 promisee 38 Aganocide 38 Fanotech 38 exclusive 38 OSNews logo 38 Sign License Agreement 38 SPL# Gel vaginal microbicide 38 sumatriptan injection 38 Sponsorship Agreement 38 BioGlue ® 38 CollaRx GENTAMICIN SURGICAL IMPLANT 38 Restoraderm R 38 Inc. OTCBB BOCL 38 Merger Sub 38 Hemopurifier ® 38 PhotoCure 38 Nihon Kohden Corporation 38 Biocon insulin 38 Biomarker Study 38 Santen Pharmaceutical 38 Applera Applied Biosystems 38 Biovitrum develops 38 RECEPTORS 38 Adaptec disclaims 38 Receives Milestone Payment 38 Morphotek 38 License 38 UMN Pharma 38 wholly owned subsidiary 38 LentiVector technology 38 Clinical Trials Agreement 38 AdVac 38 reacquires 38 NQCI 38 Mulgravian 38 Enters Into Collaboration 38 eligen R technology 38 PrevOnco 38 FMEC 38 Stem Cell Sciences 38 ImQuest Pharmaceuticals 38 Shanghai Wanxing 38 CoTherix logo 38 BioWa 38 Axenohl 38 Lantibio 38 ICEM CFD 38 Initiates Dosing 38 Farmout 38 Cabilly II 38 Distribution Agreements 38 Merz Pharmaceuticals GmbH 38 Onalta 38 Stock Purchase Agreements 38 Symphony Dynamo 38 Wellstat 38 pediatric exclusivity 38 Tego Biosciences 38 commercialize teduglutide outside 38 AmpliMed 38 Elizabethton Newspapers 38 Campto 38 secured promissory note 38 Hextend 38 Sarnoff TakeCharge 38 User Content 38 CLIA Clinical 38 Oncobionic 38 volociximab 38 Linux infringes 38 Affibody 38 therapeutic monoclonal antibodies 38 Vitaros R 38 RYZOLT 38 IntegraGen 38 Emezine 38 Agios Pharmaceuticals 38 IDOLS television brand 38 Ceragenix 38 Diamedix 38 Oswaldo Cruz 38 Cellegy 38 subsidiary Embryome Sciences 38 competitively procured pursuant 38 Marcadia 38 assignee 38 assignors 38 Poly ICR 38 VIVITROL ® 38 Tectane Technologies Corporation 38 Public License MPL 38 methylnaltrexone 38 Licensee 38 BioInvent 38 vivo fluorescence imaging 38 Company Limited iASPEC 38 Benicar HCT 38 Hyundai Syscomm 38 QLT USA 38 Targeted Chemotherapy 38 Esprit Pharma 38 Shenzhen iASPEC Software 38 RapMAT R 38 publish reproduce 38 AQUA ® 38 Free Documentation License 38 Joint Venture 38 developing Zerenex ferric 38 SPORTSTM EA MobileTM 38 Minera Guaira 38 STEDESA 38 Signs Licensing Agreement 38 defensin mimetic antibiotic 38 ProBioGen 38 Aptamer 38 optionor 38 definitive agreements 38 POTELLIGENT ® 38 Victorinox AG 38 Gareste 38 Creative Commons Attribution Noncommercial 38 OncoTherapy Science 38 VeroScience LLC 38 Solzira 38 Retavase 38 Ethypharm SA 38 SensiGen 38 Endotis 38 LibraGen 38 KIDK TV 38 Alpharma Pharmaceuticals 38 Joyful Journey West 38 dermatological indications 38 Enters Into License Agreement 38 Tolkien Enterprises 38 Banner Pharmacaps Inc. 38 Alligator Bioscience AB 38 Stem Cell Innovations 38 Sangamo ZFP technology 38 Scancell 38 Syncria 38 UNIX copyrights 38 product candidate Lpathomab 38 Angioblast 38 MultiGEN 38 Digna Biotech 38 Signs License Agreement 38 EP #R 38 Affitech 38 extracting alumina 38 Nektar PEGylation technology 38 Glenmark Pharmaceuticals Ltd. 38 NeuroSolutions 38 Glycosan 38 Option Agreements 38 candidate custirsen 38 Glassia 38 antibody humanization 38 Abnova 38 CysDisplay 37 molecular chaperone regulation 37 HepDirect 37 RECOTHROM R 37 ConstantSync Constant Synchronization 37 TKM Ebola 37 ENZON 37 mGluR2 positive 37 Letter Agreement 37 Faes Farma 37 Corporation NASDAQ SANYY 37 Patent Covering 37 commercialized DURECT 37 theranostic 37 Ampligen r 37 TVI Subscription Agreement 37 Raven Biotechnologies 37 ELADUR TM 37 DIABECELL 37 Announce License Agreement 37 label Lipofen R 37 Aero Exhaust mufflers 37 ZALBIN 37 ZOR 37 Dealmaking Profile 37 Kyorin Pharmaceutical 37 optionee 37 Uracyst 37 GlaxoSmithKline Biologicals GSK 37 CORLUX CORT # 37 parties hereto 37 Lexiscan ® 37 hand sanitizer patch 37 sumatriptan DosePro 37 Stimuvax R 37 OTCBB CNOZ 37 Incorporated Nasdaq REFR 37 Captisol enabled 37 Locked Nucleic Acid 37 Roche Trimeris 37 InSite reliance 37 AeroLEF R 37 manufacture PolyHeme 37 BCGI Shareholders 37 Mosaid patents 37 ZaBeCor 37 Amex MRM 37 copyright holder 37 Kyowa Hakko Kogyo 37 cysteamine 37 Generx TM 37 RHEI 37 Nano Terra 37 elbion GmbH 37 Specialised Therapeutics Australia 37 Milestone Payments 37 Currently RegeneRx 37 Orphan Drug designation 37 compound KOS 37 SMARTICLES ® 37 farmouts 37 ALLEGRA ® 37 Alzheimer Immunotherapy Program 37 Angioblast Systems 37 return royalty NSR 37 Xoma 37 SMaRT ™ 37 Ludesi AB 37 NovaBay Aganocide compounds 37 VividLogic 37 miRNA therapeutics 37 WSPP 37 Share Alike license 37 Lovaza TM 37 regenerative therapeutics 37 R bivalirudin 37 GEM #S 37 secured convertible promissory 37 ShareAlike 37 Stedesa 37 PharmaNova 37 Lexiscan TM 37 Sign Licensing Agreement 37 Mhakari 37 BBI# 37 core polysaccharide 37 Teuto 37 Neuromed Pharmaceuticals Ltd. 37 Kyto 37 natural sweetness enhancer 37 Systemic Delivery 37 TACLONEX 37 GPLv2 license 37 NanoTab 37 Urokinase 37 DOV Pharmaceutical Inc. 37 romazarit 37 tetrabenazine 37 Inc. Amex CTT 37 Secures Exclusive 37 Cerner Cerner Cerner Millennium 37 JCR Pharmaceuticals 37 Shire BioChem Inc. 37 Relieva 37 terminable 37 LSE CVA leading 37 codevelopment 37 KALBITOR ® 37 NASDAQ ISIS 37 Exclusivity Agreement 37 EBx ® 37 TolerRx 37 Asubio 37 dutogliptin 37 Iluvien ® 37 Sublinox 37 Psivida 37 VNUS patents 37 Nasdaq OMER 37 Nippon Shinyaku Co. 37 infringing patents 37 TradeMarkCo 37 Kiadis